
Paclitaxel: What has been done and the challenges remain ahead
Keywords: CN; chemotherapy naïve; CR; complete response; CrEL; Cremophor EL; DLT; dose limiting toxicities; DOPC; 1,2-dioleoyl-sn-glycero-3-phosphocholine; DOTAP; 1,2-dioleoyl-3-Trimethylammonium Propane; DTIC; dacarbazine; ET; Endo-Tag1®; FDA; Food and Drug Admi